LIC revenue rose 6.7% but PBT and NPAT each fell over 30%

The divergence is the central story: top-line growth did not flow through to earnings, pointing to cost growth outpacing revenue rather than a one-off distortion, since the effective tax rate (24.2% versus 23.9% prior) explains almost none of the PBT-to-NPAT gap.

Total assets rose to $408.5m, an unprecedented high against a historical range of $358.6m–$392.0m, funded through equity growth with the co-operative remaining debt-free (gross borrowings of $0). Operating cash flow fell 11.1% to $50.1m, and working capital absorbed $1.4m, sitting at the upper edge of LIC's range and well above the historical average pattern of net releases.

PBT margin held near its historical norm at 8.9% (versus a 9.0% mean), but segment detail shows International margin falling from 18.5% to 14.3% and NZ market genetics easing from 26.0% to 25.1%, while Testing and Farm software margins improved. The net effect is that revenue growth in lower-margin or margin-compressing segments diluted overall profit growth, which means investors should track segment margin trends rather than the consolidated top line alone.

Dividend sustained on a smaller profit base. The full-year dividend was effectively flat at 12.26 cents per share versus 12.22 cents prior, but because NPAT fell 30.4%, the payout ratio against NPAT rose to 81.7% from 55.5%. This matters because a larger share of a smaller profit pool is now funding distributions, reducing the buffer if earnings do not recover.

Elevated working-capital absorption alongside asset growth. The $1.4m working-capital build sits above LIC's typical pattern of net releases, and total assets are at an unprecedented $408.5m. This combination signals more capital tied up in the balance sheet without a commensurate lift in profit, which is relevant to future free cash flow even though no debt was drawn to fund it.

The available shape context is nonetheless notable: half-year NPAT of $33.8m represented 158.6% of the full-year figure, meaning the implied second-half result was a loss of roughly $12.5m, a sharp reversal from the first-half run rate.

Without management commentary specifically addressing what drove this second-half swing, the release supports a read of a strong first half followed by a materially weaker second half, but it does not establish whether the deterioration is structural or timing-related.

That distinction matters because a cash-conversion metric that looks better on paper can still reflect softer underlying trading if the improvement is capex-driven rather than earnings-driven.

The elevated working-capital build adds a further durability question, absorbing cash that would otherwise support free cash flow or dividend cover. Combined with the sharp implied second-half profit reversal, the result looks more timing-sensitive than the flat headline margins suggest.

This briefing cannot assess the underlying drivers of the second-half profit reversal or the specific cost lines behind margin compression, as neither is disclosed in the supplied extracts.